Salarius Pharmaceuticals Inc (SLRX) — Financial Flexibility Index
Salarius Pharmaceuticals Inc (SLRX) has a Financial Flexibility Index of -0.89x as of September 2025. Free cash flow of $-1.65 Million (operating CF $-1.65 Million minus capex $0.00) represents -1% of total liabilities ($1.85 Million). Also explore SLRX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Salarius Pharmaceuticals Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Salarius Pharmaceuticals Inc across 10 annual periods. Check asset allocation strategy of Salarius Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Salarius Pharmaceuticals Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Salarius Pharmaceuticals Inc. For the full company profile including market capitalisation, see Salarius Pharmaceuticals Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.99x | $-4.53 Million | $-4.53 Million | $1.51 Million | ▲ +69.7% |
| 2023 | -9.89x | $-12.85 Million | $-12.85 Million | $1.30 Million | ▼ -162.1% |
| 2022 | -3.77x | $-16.10 Million | $-17.60 Million | $4.27 Million | ▲ +21.9% |
| 2021 | -4.83x | $-10.20 Million | $-10.20 Million | $2.11 Million | ▼ -30.0% |
| 2020 | -3.72x | $-10.31 Million | $-10.31 Million | $2.77 Million | ▼ -6.4% |
| 2019 | -3.49x | $-11.58 Million | $-11.58 Million | $3.31 Million | ▲ +83.6% |
| 2018 | -21.32x | $-23.60 Million | $-23.60 Million | $1.11 Million | ▼ -354.5% |
| 2017 | -4.69x | $-27.61 Million | $-27.72 Million | $5.89 Million | ▲ +42.0% |
| 2016 | -8.08x | $-31.49 Million | $-32.05 Million | $3.90 Million | ▼ -13.5% |
| 2015 | -7.12x | $-20.48 Million | $-20.75 Million | $2.88 Million | — |